Transcutaneous Spinal Cord Stimulation for Parkinson Disease
1 other identifier
interventional
5
1 country
1
Brief Summary
Spinal cord stimulation has been used to treat gait problems in Parkinson's disease, with positive results along some studies. The use of non-invasive stimulation can be an alternative to stimulate the spinal corn.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable parkinson-disease
Started Oct 2019
Shorter than P25 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2019
CompletedFirst Submitted
Initial submission to the registry
November 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2019
CompletedFirst Posted
Study publicly available on registry
November 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2019
CompletedNovember 20, 2019
November 1, 2019
1 month
November 10, 2019
November 18, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Freezing of gait score
The primary outcome is the freezing of gait score. 12-item scale, each item scores 3 points at maximum; the score ranges from 0-36; higher scores mean higher severity
One week
Secondary Outcomes (4)
Gait speed
baseline, 1 week, 4 week
Freezing of gait questionnaire
baseline, 1 week, 4 week
Safety of the intervention - urinary incontinence
1 week, 4 week
Safety of the intervention - lower limb strength.
1 week, 4 week
Study Arms (1)
Intervention
EXPERIMENTALIntervention: non-invasive spinal cord stimulation
Interventions
Theta burst stimulation at thoracic level (T5) over 2 minutes
Eligibility Criteria
You may qualify if:
- diagnosis of advanced idiopathic Parkinson's disease
- significant freezing of gait despite optimized treatment with medications and rehabilitation program
You may not qualify if:
- psychiatric symptoms
- dementia
- cardiac pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of São Paulo
São Paulo, São Paulo, 05403-000, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
November 10, 2019
First Posted
November 20, 2019
Study Start
October 15, 2019
Primary Completion
November 15, 2019
Study Completion
November 30, 2019
Last Updated
November 20, 2019
Record last verified: 2019-11